» Articles » PMID: 34851606

Engineered L-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments

Overview
Journal ACS Synth Biol
Date 2021 Dec 1
PMID 34851606
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteria equipped with genetically encoded lactate biosensors are promising tools for biopharmaceutical production, diagnostics, and cellular therapies. However, many applications involve glucose-rich and anoxic environments, in which current whole-cell lactate biosensors show low performance. Here we engineer an optimized, synthetic lactate biosensor system by repurposing the natural LldPRD promoter regulated by the LldR transcriptional regulator. We removed glucose catabolite and anoxic repression by designing a hybrid promoter, containing LldR operators and tuned both regulator and reporter gene expressions to optimize biosensor signal-to-noise ratio. The resulting lactate biosensor, termed ALPaGA (A Lactate Promoter Operating in Glucose and Anoxia), can operate in glucose-rich, aerobic and anoxic conditions. We show that ALPaGA works reliably in the probiotic chassisNissle 1917 and can detect endogenous l-lactate produced by 3D tumor spheroids with an improved dynamic range. In the future, the ALPaGA system could be used to monitor bioproduction processes and improve the specificity of engineered bacterial cancer therapies by restricting their activity to the lactate-rich microenvironment of solid tumors.

Citing Articles

Precision tumor treatment utilizing bacteria: principles and future perspectives.

Liu Z, Wang L, Wu P, Yuan L Appl Microbiol Biotechnol. 2025; 109(1):2.

PMID: 39754636 PMC: 11700060. DOI: 10.1007/s00253-024-13378-x.


Microbial biosensors for diagnostics, surveillance and epidemiology: Today's achievements and tomorrow's prospects.

Capin J, Chabert E, Zuniga A, Bonnet J Microb Biotechnol. 2024; 17(11):e70047.

PMID: 39548716 PMC: 11568237. DOI: 10.1111/1751-7915.70047.


Synergistic effects of bacteria, enzymes, and cyclic mechanical stresses on the bond strength of composite restorations.

Montoya C, Babariya M, Ogwo C, Querido W, Patel J, Melo M Biomater Adv. 2024; 166:214049.

PMID: 39368439 PMC: 11560555. DOI: 10.1016/j.bioadv.2024.214049.


Engineered as oral probiotics to enhance clearance of blood lactate.

Yang M, Hutchinson N, Ye N, Yin J, Guan M, Wang Z bioRxiv. 2023; .

PMID: 38076834 PMC: 10705430. DOI: 10.1101/2023.11.30.569300.


Characterization of Eight Bacterial Biosensors for Microbial Diagnostic and Therapeutic Applications.

Vaaben T, Vazquez-Uribe R, Sommer M ACS Synth Biol. 2022; 11(12):4184-4192.

PMID: 36449712 PMC: 9764412. DOI: 10.1021/acssynbio.2c00491.


References
1.
Goers L, Ainsworth C, Goey C, Kontoravdi C, Freemont P, Polizzi K . Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production. Biotechnol Bioeng. 2017; 114(6):1290-1300. PMC: 5412874. DOI: 10.1002/bit.26254. View

2.
Yang D, Kim W, Yoo S, Choi J, Ha S, Lee M . Repurposing type III polyketide synthase as a malonyl-CoA biosensor for metabolic engineering in bacteria. Proc Natl Acad Sci U S A. 2018; 115(40):9835-9844. PMC: 6176597. DOI: 10.1073/pnas.1808567115. View

3.
Courbet A, Endy D, Renard E, Molina F, Bonnet J . Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates. Sci Transl Med. 2015; 7(289):289ra83. DOI: 10.1126/scitranslmed.aaa3601. View

4.
Lasprilla A, Martinez G, Lunelli B, Jardini A, Filho R . Poly-lactic acid synthesis for application in biomedical devices - a review. Biotechnol Adv. 2011; 30(1):321-8. DOI: 10.1016/j.biotechadv.2011.06.019. View

5.
Chen Y, Ho J, Shis D, Gupta C, Long J, Wagner D . Tuning the dynamic range of bacterial promoters regulated by ligand-inducible transcription factors. Nat Commun. 2018; 9(1):64. PMC: 5754348. DOI: 10.1038/s41467-017-02473-5. View